CNS Pharmaceuticals (CNSP) Total Debt (2018 - 2025)
CNS Pharmaceuticals (CNSP) reported Total Debt of $328,571 for Q4 2025, up 0.8% from $326,072 a year earlier and up 967.0% from the prior quarter.
Powered by 
Analysis
CNS Pharmaceuticals (CNSP) Total Debt (2018 - 2025) Analysis & Trends
Dating back to Q4 2018, CNS Pharmaceuticals' Total Debt record includes 23 quarters.
- Total Debt has a five-year compound annual growth rate of -5.6% (FY2020 to FY2025).
- By year, Total Debt came in at $326,072 in FY2024 (+8.4%), $300,806 in FY2023 (-26.6%), $409,968 in FY2022 (+5.7%) and $387,794 in FY2021 (-11.7%).
- The Q4 2025 figure ranks as the highest quarterly Total Debt since Q4 2022.
- Year over year, Total Debt gained in two of the last eight quarters, with an average decline of 9.0%.
- The high point for year-over-year Total Debt in five years was Q4 2024 (growth of 8.4%); the low point was Q4 2023 (a decline of 26.6%).
- Per Business Quant data, the three quarters before Q4 2025 came in at $30,793 (Q3 2025), $121,767 (Q2 2025) and $210,673 (Q1 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 49.04 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 70.82 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 53.91 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 37.49 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -111.00 Mn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 57.30 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 26.25 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 63.19 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | - |
| 10 | CNS Pharmaceuticals | 2.30 Mn | -39.94 Mn | - | 328,571.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 328,571.00 |
| Sep 30, 2025 | 30,793.00 |
| Jun 30, 2025 | 121,767.00 |
| Mar 31, 2025 | 210,673.00 |
| Dec 31, 2024 | 326,072.00 |
| Sep 30, 2024 | 31,187.00 |
| Jun 30, 2024 | 123,248.00 |
| Mar 31, 2024 | 213,104.00 |
| Dec 31, 2023 | 300,806.00 |
| Sep 30, 2023 | 41,904.00 |
| Jun 30, 2023 | 166,396.00 |
| Mar 31, 2023 | 289,075.00 |
| Dec 31, 2022 | 409,968.00 |
| Sep 30, 2022 | 39,260.00 |
| Jun 30, 2022 | 156,397.00 |
| Mar 31, 2022 | 272,572.00 |
| Dec 31, 2021 | 387,794.00 |
| Sep 30, 2021 | 44,632.00 |
| Jun 30, 2021 | 177,583.00 |
| Mar 31, 2021 | 309,133.00 |
API Access
CNS Pharmaceuticals Total Debt API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-debt&ticker=CNSP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-debt", "ticker": "CNSP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-debt&ticker=CNSP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();